news
Petrovax Pharm receives a license from the Russian Ministry of Industry and Trade for production of meningococcal vaccine
Local production of the vaccine represents an important step toward launching routine immunization in line with the Strategy for the Development of Immunoprophylaxis of Infectious Diseases in the Russian Federation
Merry Christmas and Happy New Year!
Camrelizumab Included in Russia’s Essential Drug List
Expanding horizons in lung cancer immunotherapy
New opportunities in scar management: the role of immobilized hyaluronidase
Representatives of the Podolsk administration visit the Petrovax Pharm manufacturing complex
Innovative immunotherapy for lung cancer authorized in Russia
How the dietary supplements market is changing in Russia: the need to shift toward medical standards
Investment project by Petrovax Pharm for market launch of Areima® wins industry award
